https://doi.org/10.31288/oftalmolzh20155712

Diagnosis and Treatment of Acanthamoeba Keratitis

Lincoln Lavado Landeo,  Ophthalmologist, Doctor of Medicine and Philosophy, Professor

San Marcos National University 

Centro Visi?n Ophthalmological Institute

Lima (Peru)

Objective: Review the clinical characteristics, diagnosis, treatment and visual results in patients diagnosed with Acanthamoeba keratitis (AK). Demonstrate the importance of early diagnosis and of prompt and effective treatment.

Material and methods: Retrospective study of 14 eyes in the same number of patients diagnosed with AK, treated at Centro Visi?n between July 2008 and June 2012. All the cases were confirmed by smear and/or culture. Two groups were established: early and late diagnosis. Treatment was carried out with propamidine and polyhexamethylene biguanide. After the infection had been eliminated, final visual acuity and duration of treatment were recorded. 

Results: The most frequently affected group was aged between 21 and 40 years (9 cases). Only two eyes (14.3%) were correctly diagnosed initially as AK. Eleven patients (78.6%) were contact lens wearers. The most common sign was diffuse infiltrate (62.3%); perineural infiltrate was only seen in one case. Five patients were diagnosed within the first thirty days (early diagnosis group) and nine cases were diagnosed later (late diagnosis group). Median visual acuity in the early diagnosis group was 20/40, and in the late diagnosis group it was 20/400. The median duration of treatment in the early diagnosis group was six months, and in the late diagnosis group it was ten months. 

Conclusions: The majority of the eyes (85.7%) were initially erroneously classified as keratitis resulting from other causes. When AK is diagnosed early there is a better visual prognosis, and also prolonged treatment will not be necessary. 

Key words: Acanthamoeba; keratitis; contact lenses; polyhexamethylene biguanide; propamidine. 

1.Ram?rez Flores E, Robles Valderrama E, Sainz Morales MG y col. Coliformes y amibas de vida libre presentes en agua subterr?nea. RevistaLatinoamericana de RecursosNaturales 2009; 5(2): 98-105.

2.Todero Wink MR, Caumo K, BrittesRott M. Prevalence of Acanthamoeba from Tap Water in Rio Grande doSul, Brazil. CurrMicrobiol 2011; 63: 464-469.
Crossref

3.Abbot RL and Elander TR. Acanthamoeba Keratitis. En: Tasman W, Jaeger EA. Duane Clinical Ophthalmology, Philadelphia: JB Lippincott, 1995; 4: 18.

4.Illingworth CD, Cook SD. Acanthamoeba Keratitis. SurvOphthalmol 1988; 42(6): 493-508.
Crossref

5.Kerr NM, Ormonde S. Acanthamoeba keratitis associated with cosmetic contact lens wear. The New Zealand Medical Journal 2008; 121 (1286).

6.Legarreta JE, Nau AC, Dhaliwal DK. Acanthamoeba keratitis associated with tap water use during contact lens cleaning: manufacturer guidelines need to change. Eye Contact Lens. 2013; 39:158-161.
Crossref

7.Donzis PB, Mondino BJ, WeissmanA et al. Microbial analysis of contact lens care systems contaminated with Acanthamoeba. Am J Ophthalmol 1989; 108: 53-56.
Crossref

8.Dua HS, Azuara-Blanco A, Hossain M et al. Non-Acanthamoeba amebic Keratitis. Cornea 1988; 17(6): 675-677.
Crossref

9.Tu EY. Acanthamoeba keratitis: A new normal. Am J of Ophthalmology 2014; 158(3): 417-419.
Crossref

10.Aasly K, Bergh K. Acanthamoeba keratitis; report of the first Norwegian cases. ActaOphthalmologica 1992; 70(5): 698-701.
Crossref

11.Carrette S, Marechal-Courtois CH, Hernandez J et al. A propos d'un cas de k?ratite ? Acanthamoeba Bull. Soc. BelgeOphtalmol 2000; 275: 49-53. 

12.Fathallah A, Rayana NB, Knani L et al. Les k?ratites ? Acanthamoeba sp. A propos de 3 cas diagnostiqu?s au centre tunisien. La Tunisie M?dicale 2010; 88(2): 111-115.

13.Walochnik J, Haller-Schober EM, Kolli H et al. Acanthamoeba-Keratitis in ?sterreich: Klinische, mikrobiologische und epidemiologische Befunde. Tropcnmcd. Parasitol 2001; 23: 17-26.

14.Skarin A, Flor?n I, Kiss K et al. Acanthamoeba keratitis in the south of Sweden. ActaOphthalmologicaScandinavica 1996; 74(6), 593–597.

15.Radford CF, Minassian DC, Dart JKG. Acanthamoeba keratitis in England and Wales: incidence, outcome, and risk factors. Br J Ophthalmol. 2002; 86(5): 536–542.

16.Souza Alvarenga L, de Freitas D, Hofling-Lima AL. Ceratite por Acanthamoeba. ArqBrasOftal 2000; 63(2): 155-159.

17.Moore MB, McCulley JP, Kaufman HE et al. Radial keratoneuritis as a presenting sign in Acanthamoeba Keratitis. Ophthalmology 1986; 104: 1310-1315.

18.Seal DV. Acanthamoeba keratitis: update-incidence, molecular epidemiology and new drugs for treatment. Eye 2003; 17: 893-905.

19.Sharma S, Garg P, Rao GN. Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis. Br J Ophthalmol 2000; 84: 1103-1108.

20.Sharma S, Srinivasan M, George C. Acanthamoeba keratitis in non-contact lens wearers. Arch Ophthalmol 1990; 108: 676-678.

21.Szentm?ry N, Goebels S, Matoula P et al. Die Akantham?benkeratitis - ein seltenes und oft sp?t diagnostiziertes Cham?leon. Klin Monatsbl Augenheilkd 2012; 229(5): 521-528.

22.Wright P, Warhust D, Jones BR. Acanthamoeba Keratitis successfully treated medically. Br J Ophthalmol 1985; 69: 778-782.

23.Bacon AS, Frazer DG, Dart JKG et al. A review of 72 consecutive cases of Acanthamoeba keratitis 1984-1992. Eye 1993; 7: 719-725.

24.Larkin DFP, Kilvington S, Dart JK. Treatment of Acanthamoeba keratitis with polyhexamethylenebiguanide. Ophthalmology 1992; 99: 185-191.

25.Bernauer W, Duguid GI, Dart JK. Zur klinischen Fr?hdiagnose der Acanthamoeben-Keratitis: Eine Studie ?ber 70 Augen. KlinMonatsblAugenheilkd 1996: 208(5); 282-284.

26.Dart JKG, Saw VPJ, Kilvington S. Acanthamoeba Keratitis: Diagnosis and Treatment Update 2009. Am J Ophthalmol 2009; 148: 487-499.

27.Del Buey MA, Crist?bal JA, Casas P et al. Evaluation of in vitro efficacy of combined riboflavin and ultraviolet A for Acanthamoeba isolates. Am J Ophthalmol 2012; 153(3): 399-404.

28.Khan YA, Kashiwabuchi RT, Martins SA et al. Riboflavin and ultraviolet light, a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. Ophthalmology 2011; 118: 324-331.

29.Mor?n H, Malmsj? M, Mortensen J, Ohrstr?m A: Riboflavin and ultraviolet A collagen crosslinking of the cornea for the treatment of keratitis. Cornea 2010; 29: 102-104.

30.Makdoumi K, Mortensen J, Crafoord S. Infectious keratitis treated with corneal crosslinking. Cornea 2010; 29(12): 1353-1358.

31.M?ller L, Thiel MA, Kipfer-Kauer AI and Kaufmann C. Corneal cross-linking as supplementary treatment option in melting keratitis: a case series. KlinischeMonatsblatterf?rAugenheilkunde 2012; 229(4): 411–415.